Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.729
EU - Europa 5.448
AS - Asia 1.497
AF - Africa 24
SA - Sud America 23
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 17
Totale 16.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.507
IT - Italia 1.544
DE - Germania 1.099
CN - Cina 799
SE - Svezia 723
IE - Irlanda 572
UA - Ucraina 323
GB - Regno Unito 300
CA - Canada 215
HK - Hong Kong 212
FI - Finlandia 150
VN - Vietnam 143
IN - India 136
DK - Danimarca 112
RU - Federazione Russa 108
AT - Austria 101
FR - Francia 100
PL - Polonia 76
BE - Belgio 51
NL - Olanda 39
TR - Turchia 37
KR - Corea 29
JP - Giappone 28
PT - Portogallo 28
ES - Italia 26
IR - Iran 25
RO - Romania 25
SG - Singapore 23
BG - Bulgaria 21
BR - Brasile 20
GR - Grecia 18
AU - Australia 17
CH - Svizzera 15
EU - Europa 14
IL - Israele 13
TW - Taiwan 12
ID - Indonesia 8
ZA - Sudafrica 7
MX - Messico 6
MY - Malesia 6
HU - Ungheria 5
IQ - Iraq 5
MU - Mauritius 5
PK - Pakistan 5
EG - Egitto 4
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
LU - Lussemburgo 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AR - Argentina 1
BD - Bangladesh 1
CY - Cipro 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
SC - Seychelles 1
TH - Thailandia 1
YE - Yemen 1
Totale 16.757
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.787
Woodbridge 866
Frankfurt am Main 674
Fairfield 670
Chandler 632
Milan 614
Wilmington 564
Houston 556
Dublin 551
Ashburn 486
Dearborn 370
Jacksonville 352
Seattle 309
Cambridge 242
New York 216
Hong Kong 197
Princeton 191
Nanjing 153
Vienna 98
Shanghai 87
Beijing 82
Helsinki 81
Kraków 74
Lawrence 72
San Diego 63
Altamura 62
Dong Ket 62
Toronto 61
Guangzhou 60
Lachine 58
Ottawa 54
Nanchang 53
Fremont 52
Brussels 47
Wayne 43
Boardman 34
Kunming 34
Andover 33
Pune 33
Rome 33
Hangzhou 31
Hebei 30
Shenyang 29
Changsha 26
Nürnberg 26
Grafing 25
Monza 25
Norwalk 24
Tianjin 23
Zhengzhou 22
Falls Church 21
Plovdiv 21
Jiaxing 20
Lecco 20
Jinan 18
Carate Brianza 17
Chicago 17
Edmonton 16
Lansing 16
Bergamo 15
London 14
Segrate 14
Washington 14
Los Angeles 13
Mountain View 13
Taizhou 13
Huizen 12
Kiev 12
Palermo 12
Sacramento 12
Auburn Hills 11
Ningbo 11
Redmond 11
San Mateo 11
Turin 11
Verona 11
Ahmedabad 10
Cesena 10
Copenhagen 10
Hefei 10
Montréal 10
Siena 10
São Paulo 10
Detroit 9
Duncan 9
New Delhi 9
Phoenix 9
Taipei 9
Amsterdam 8
Genova 8
Lissone 8
Pavia 8
Porto 8
Stezzano 8
Zanjan 8
Central 7
Como 7
Daejeon 7
Dallas 7
Mumbai 7
Totale 12.549
Salva come PNG Salva come JPEG
Nome #
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 460
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 428
A new approach for glyco-functionalization of collagen-based biomaterials 359
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 355
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 352
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 346
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 343
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 321
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 321
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 306
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 303
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 303
Phage-displayed peptides targeting specific tissues and organs 288
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 269
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 263
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 249
Nanomedicine for the treatment of Alzheimer's disease 248
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 241
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 238
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 226
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 226
Are the nanoparticles friends or foes when inhaled? 219
TrkA pathway activation induced by amyloid-beta (Abeta) 218
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 217
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 216
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 215
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 214
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 212
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 212
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 210
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 195
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 193
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 191
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 186
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 186
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 181
Enhanced brain targeting of engineered solid lipid nanoparticles 180
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 179
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 178
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 178
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 177
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 176
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 174
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model 174
Effect of modified collagen on amyloid beta peptide aggregation 174
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 170
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 167
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 167
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 163
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 161
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 159
Enhanced brain targeting of engineered solid lipid nanoparticles 155
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 151
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 149
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 149
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 148
Nanotechnology for neurodegenerative disorders 146
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 144
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 139
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 136
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 135
Nanotechnology for neurodegenerative disorders 135
Effect of curcumin-associated and lipid ligand functionalised nanoliposomes on aggregation of the Alzheimer's Aβ peptide 134
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 133
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 130
Applications of Surface Plasmon Resonance (SPR) for the Characterization of Nanoparticles Developed for Biomedical Purposes 129
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide 128
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 128
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 127
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 126
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 124
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 124
Self-assembled electrical biodetector based on reduced graphene oxide 123
Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer’s disease murine model 122
Design and validation of a microfluidic device for blood-brain barrier monitoring and transport studies 121
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 118
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 118
Nanoparticles for neuroimaging 117
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 117
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 115
Liposomes capable of effectively binding the beta-amyloid peptide 114
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 113
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 112
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 111
Amyposomes: a new nanomedicine for therapy of Alzheimer disease, waiting for clinical trials 108
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 106
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 105
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 90
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 90
Nanoparticles modulate the stability of the nuclear structure interfering in the mechanical connection between plasma membrane and nucleus 88
Design of nanoparticles for the treatment of brain tumors 86
Liposomes containing acid lipids and functionalized with a peptide eliciting an efficient removal of beta-amyloid peptide burden from the brain of animal models (transgenic mice) of Alzheimer disease. 85
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 85
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 78
Small hexokinase 1 peptide against toxic sod1 g93a mitochondrial accumulation in als rescues the atp-related respiration 44
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 40
TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells 38
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 38
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 36
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 34
Totale 17.509
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.634
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019701 0 0 0 0 0 0 0 0 0 236 216 249
2019/20203.213 326 179 168 219 289 375 503 317 309 232 217 79
2020/20213.055 161 139 306 277 222 277 284 275 278 299 215 322
2021/20222.187 200 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20241.930 64 81 132 161 240 542 410 117 134 49 0 0
Totale 17.594